About Wolverine Venture Fund
Wolverine Venture Fund is a venture capital firm founded in 1997. It is primarily based out of Ann Arbor, United States. As of Feb 2017, Wolverine Venture Fund has invested in 21 companies. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to Enterprise Applications and High Tech. Most recently it participated in the $***** Series B round of HistoSonics Overall, Wolverine Venture Fund portfolio has seen 7 acquisitions including key companies like HistoSonics, NeuMoDx and HandyLab. A lot of funds co-invest with Wolverine Venture Fund, with names like Arboretum Ventures sharing a substantial percentage of its portfolio. Wolverine Venture Fund has team of 13 people including 3 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Seed & 4 more
Portfolio Acquisitions
Portfolio Soonicorns
Wolverine Venture Fund's List of Top Investments
Wolverine Venture Fund has a portfolio of 21 companies. Their most notable investments are in Conversa Health and Arbor Photonics.Their portfolio spans across and United States. They have invested in Life Sciences, Enterprise Applications, High Tech and 11 other sectors, across stages such as Series A, Seed and 4 more. Here is the list of top investments by Wolverine Venture Fund:1. HistoSonics
HistoSonics is developing Histotripsy technology, licensed from the University of Michigan. It is a non-invasive, image guided therapeutic ultrasound system that excises tissue. Uses pulsed sound waves to induce cavitation that mechanically destroys tissue, tumors and plaque at the cellular level. Application areas include cardiovascular, oncology, neurology and urology.
Key facts about HistoSonics
- Founded Year: 2009
- Location: Ann Arbor (United States)
- Last Known Valuation: $*****
- Stage: Acquired
- Total Funding till date: $566M
- Employee Count: 402 as on May 31, 2026
- Investors: Founders Fund, Amzak Health and 26 Others
- Latest Funding Round: Series E, Jun 22, 2026, $*****
- Highlight: Acquired
2. IntelePeer
AI-powered communications automation solutions. The platform offers smart automation solutions for patient communication, enterprise omnichannel AI communications, messaging communications, and customer service for banks and financial institutions. Its platform is powered by generative AI, providing automated omnichannel communications for voice, SMS, and social media.
Key facts about IntelePeer
- Founded Year: 2003
- Location: Dania Beach (United States)
- Stage: Series E
- Total Funding till date: $233M
- Employee Count: 299 as on May 31, 2026
- Investors: Hercules Capital, Sixth Street and 20 Others
- Latest Funding Round: Conventional Debt, Jul 25, 2024, $*****
- Highlight: Editors' Pick
3. Elucid
AI-based arterial analysis software for providers. The company has developed software that assists with different clinical diagnostic analyses. It has features for clinical research, personalized patient care, stroke prediction, and more.
Key facts about Elucid
- Founded Year: 2013
- Location: Boston (United States)
- Stage: Series C
- Total Funding till date: $152M
- Employee Count: 143 as on May 31, 2026
- Investors: IAG Capital Partners, Lifeblood and 9 Others
- Latest Funding Round: Series C, Oct 10, 2025, $*****
- Highlight: Editors' Pick
4. NeuMoDx
NeuMoDx is developing a patent-pending platform for low-cost molecular testing. It integrates magnetic particle affinity capture and real-time Polymerase Chain Reaction (PCR) chemistry in a multi-sample microfluidic cartridge. Its lead product NeuMoDx 500 is a molecular IVD system that is a fully automated, random access platform capable of performing RNA and DNA-based assays.
Key facts about NeuMoDx
- Founded Year: 2012
- Location: Ann Arbor (United States)
- Last Known Valuation: $*****
- Stage: Acquired
- Total Funding till date: $66M
- Employee Count: 125 as on Dec 31, 2022
- Investors: Arboretum Ventures, Venture Investors and 3 Others
- Latest Funding Round: Series B, Apr 27, 2018, $*****
- Highlight: Acquired
Delphinus Medical Technologies has designed and developed SoftVue, a three-dimensional and tomographic ultrasound imaging and risk assessment device that examines women’s breasts for the presence of benign and/or malignant masses, assesses breast cancer risks, diagnoses breast diseases, and monitors therapy. Sound and water are the basis of its technology, where acoustic signals resonating within breast tissue yield a unique signature that it measures. SoftVue has received FDA clearance for diagnostic imaging purposes and is not intended for use as a replacement for screening mammography.
Key facts about Delphinus Medical Technologies
- Founded Year: 2010
- Location: Plymouth (United States)
- Stage: Series D
- Total Funding till date: $137M
- Employee Count: 61 as on Apr 03, 2025
- Investors: Trinity Capital, GE Capital and 11 Others
- Latest Funding Round: Series D, Mar 22, 2024, $*****
- Highlight: Editors' Pick
Wolverine Venture Fund's Year-on-Year Investment Trends
Wolverine Venture Fund has invested in 21 companies over the last 26 years, with an average of 0 new investment annually in the last 10 years. Its most recent first time investment was in HistoSonics and most recent follow-on round was in NeuMoDx.Wolverine Venture Fund's Investments by Stage
Wolverine Venture Fund has made 4 investments in Series A stage with an average round size of $5.07M, 2 investments in Seed stage with an average round size of $50K and 2 investments in Series B stage with an average round size of $7.65M.Stage of entry | No. of Investments |
|---|---|
Series A | 4 |
Seed | 2 |
Series B | 2 |
Series C | 1 |
Series D | 1 |
Others | 1 |
Note: We have considered here, only first round of investments
Wolverine Venture Fund's Investments by Sector
Wolverine Venture Fund has a diverse portfolio, with companies operating in the Life Sciences, High Tech, Enterprise Applications, HealthTech and Sustainability Tech. Notably, it has invested in 19 Enterprise (B2B) companies, 19 Tech companies, 12 Software companies and at least 6 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
Life Sciences | 7 |
High Tech | 5 |
Enterprise Applications | 3 |
HealthTech | 3 |
Sustainability Tech | 2 |
Others | 4 |
Note: We have considered here, only first round of investments
Wolverine Venture Fund's Investments by Geography
Wolverine Venture Fund has made most investments in United States (11).Wolverine Venture Fund's recent investments
Wolverine Venture Fund has not made any investment in 2026 so far.Here are the most recent investments by Wolverine Venture Fund:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Feb 08, 2017 | United States | Series B | 1989 | [+6] | |
Apr 26, 2016 | United States | Seed | 4987 | ||
Mar 26, 2014 | United States | Series B | 1910 | [+3] | |
Jul 10, 2013 | United States | Series B | 5256 | [+1] | |
May 23, 2012 | United States | Series D | 7589 | [+4] |
Acquired companies in Wolverine Venture Fund's Portfolio
7 companies from Wolverine Venture Fund's portfolio have been acquired. The most recent acquisition was HistoSonics in Aug 2025 by K5 Global for $*****.Here are Wolverine Venture Fund's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Aug 07, 2025 | Feb 08, 2017 | Series B | 6511 | |
Jul 28, 2021 | Apr 26, 2016 | Seed | 1794 | |
Sep 17, 2020 | Apr 09, 2012 | Series A | 7701 | |
Apr 10, 2014 | - | - | 9354 | |
Jan 07, 2013 | Mar 05, 2009 | Series A | 2639 |
Team profile of Wolverine Venture Fund
Wolverine Venture Fund has a team of 13 members including 3 Partners located in United States. Wolverine Venture Fund's team does not sit on the board of any company as of now.Here is a list of top team members in Wolverine Venture Fund:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | - | - | - | |
Partner | Ann Arbor | - | - | |
Partner | Ann Arbor | - | - |
Co-investors of Wolverine Venture Fund
Over the past 26 years, 84 investors have co-invested in Wolverine Venture Fund's portfolio companies. This includes funds and angels.
- Invested before Wolverine Venture Fund: Arboretum Ventures, Venture Investors and 18 others have invested in rounds before Wolverine Venture Fund. There are 2 companies where Arboretum Ventures has invested before Wolverine Venture Fund and 1 company where Venture Investors has invested before Wolverine Venture Fund.
- Top Co-investors of Wolverine Venture Fund: 10 investors entered a company along with Wolverine Venture Fund. These include investors like Arboretum Ventures (2 companies).
- Invested after Wolverine Venture Fund: A total of 54 investors have invested in Wolverine Venture Fund's portfolio after their investments. Top Investors include Venture Investors (3 companies), HHS (2 companies) and National Science Foundation (2 companies).
Recent News related to Wolverine Venture Fund
•
•
•
•
•
Wolverine Venture Fund Invests in Direct Flow Medical |FinSMEsFinSMEs•Oct 12, 2009•Direct Flow Medical, JJDC, VantagePoint Capital Partners, EPlanet Capital and 4 others
•
•
